Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
396,295
-
Shares change
-
-669,555
-
Total reported value, excl. options
-
$861,000
-
Value change
-
-$1,432,231
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$2.18
Significant Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q4 2017
13 filings reported holding PRPH - ProPhase Labs, Inc. - COM as of Q4 2017.
ProPhase Labs, Inc. - COM (PRPH) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 396,295 shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (165,417 shares), Bank of New York Mellon Corp (118,154 shares), PNC FINANCIAL SERVICES GROUP, INC. (25,402 shares), DEUTSCHE BANK AG\ (18,646 shares), UBS Group AG (17,100 shares), NORTHERN TRUST CORP (15,137 shares), ACADIAN ASSET MANAGEMENT LLC (13,768 shares), CITADEL ADVISORS LLC (11,821 shares), COMMONWEALTH EQUITY SERVICES, LLC. (10,000 shares), and MORGAN STANLEY (850 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.